surpass cvot tirzepatide Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial Diabetes Distilled: SURPASS-CVOT – Tirzepatide

Lilly has been offering the vials only to patients paying on their own without insurance, also known as self-pay

Patients should maintain adequate hydration and seek prompt medical advice if persistent vomiting, diarrhoea, or signs of dehydration occur

This is an important point for readers because people often assume that if a medicine is talked about in the news, it must now be easy to get from a GP

Tuesday 21 October (Central Daylight Time six hours behind UK time) Core Interactive Session Translating OSA Endophenotyping into Clinical Trials (91510:15am CDT) Rapid-Fire Oral: SynAIRgy Phase 3 Trial 1:451:50pm CDT Poster: LunAIRo 51-week Phase 3 Trial 1:452:30pm CDT Additional posters explore the impact of OSA on productivity and the economic burden of fatigue and daytime sleepiness